Mildin (Loratadine)

Loratadine, the active ingredient in Mildin, is a second‑generation antihistamine presented as an oral dosage form for oral use. It selectively blocks peripheral H1‑receptors, helping to relieve sneezing, itching, watery eyes and runny nose in patients with allergic conditions.

GNH USA supplies Mildin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mildin (loratadine) is used to manage allergic disorders that involve histamine‑mediated symptoms. - Allergic rhinitis: reduces nasal congestion, sneezing and itching caused by seasonal or perennial allergens. - Seasonal allergic conjunctivitis: alleviates itchy, red, watery eyes associated with pollen exposure. - Chronic idiopathic urticaria: diminishes the frequency and severity of hives and associated itching.

Loratadine is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Dry mouth: transient sensation of oral dryness. - Fatigue: occasional tiredness without impairment of daily activities. - Nausea: mild stomach upset that usually resolves spontaneously. - Drowsiness (rare for second‑generation agents): occasional mild sedation.

Serious or Rare Side Effects: - Rash or hives: signs of possible hypersensitivity. - Swelling of face, lips or tongue: indicates angio‑edema and requires urgent care. - Difficulty breathing: potential anaphylactic reaction. - Palpitations or irregular heartbeat: rare cardiac effects.

Before using Mildin, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential exposure to the infant with a clinician. - Liver impairment: dose adjustment may be required in severe cases. - Concomitant sedatives: monitor for additive drowsiness. - Age considerations: use with caution in children under 2 years unless directed by a physician. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Loratadine may interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Ketoconazole or erythromycin: may increase loratadine plasma levels, raising risk of side effects. - Antifungal agents (e.g., itraconazole): can significantly raise loratadine concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance drowsiness in sensitive individuals. - CNS depressants (e.g., benzodiazepines): monitor for additive sedation. - Other antihistamines: combined use may increase anticholinergic burden. - Theophylline: may experience altered metabolism; observe therapeutic response.